Related Experiment Video

Updated: Jul 13, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

[Recent advances in the prognostic evaluation of non-ischemic dilated cardiomyopathy]

Rosa Sicari

    Recenti Progressi in Medicina
    |August 10, 2007
    PubMed

    Insights

    Stress echocardiography aids in early heart failure detection and risk stratification. This imaging technique identifies patients with better outcomes, even in advanced stages, offering valuable insights for dilated cardiomyopathy management.

    Area of Science:

    • Cardiology
    • Medical Imaging
    • Heart Failure Research

    Background:

    • Heart failure is a progressive syndrome with variable deterioration rates influenced by overload causes and patient age.
    • Asymptomatic left ventricular dysfunction often precedes rapid symptom progression in heart failure.
    • Stress echocardiography is valuable in both early and advanced heart failure stages.

    Discussion:

    • In early stages, reduced inotropic reserve detected by stress echocardiography can reveal initial cardiac damage.
    • Advanced stages benefit from stress echocardiography identifying patients with better prognoses despite similar resting LV function.
    • Pharmacological stressors like dipyridamole or dobutamine safely induce contractile reserve, with vasodilator stress also assessing coronary flow reserve.

    Key Insights:

    • Stress echocardiography effectively unmasks early left ventricular dysfunction.
    • It stratifies risk in advanced heart failure, identifying subgroups with favorable outcomes.
    • The technique integrates functional and perfusion data, crucial for comprehensive patient assessment.

    Outlook:

    • Rest and stress echocardiography are ideal for dilated cardiomyopathy due to cost-effectiveness, availability, and safety.
    • Further research may refine stress echocardiography protocols for enhanced heart failure management.
    • Integrating functional and perfusion data offers a holistic view for personalized cardiac care.

    Related Concept Videos

    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...